SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew who wrote (2449)8/27/1999 7:17:00 PM
From: John Metcalf  Read Replies (1) of 2742
 
It is not likely that information would leak from Genome Securities. They are a three-person firm in Scranton, PA.

There will be offers for Cistron, because they have 8 figures in cash. Someone will at least offer the cash value, in order to get CIST's patents, royalties (tiny) and HMR deal potential for free.

A cash-strapped company might acquire CIST for stock at current value, which would be equivalent to selling shares without discount.

Yes, there will be offers.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext